HSP90AA1 and nasopharyngeal carcinoma: Previous research has shown that Hsp90 inhibitors exhibit significant anti-tumor properties in NPC, such as the inhibition of cell growth, induction of apoptosis, and suppression of invasion and metastasis [6,13,14,15].